Pentoxifylline in Treatment of Patients With Nonalcoholic Steatohepatitis

PHASE3CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

February 1, 2022

Primary Completion Date

September 1, 2022

Study Completion Date

October 1, 2022

Conditions

NASH - Nonalcoholic Steatohepatitis

Interventions

DRUG

pentoxifylline (Trental SR®)

400 mg three times daily

Trial Locations (1)

Internal medicine and hepatology outpatient clinic at Ain Shams University Hospital., Cairo

All Listed Sponsors

lead

Al-Azhar University

OTHER